Related by context. All words. (Click for frequent words.) 77 YONDELIS 76 Aflibercept 75 nucleoside analog 75 Sapacitabine 74 multi kinase inhibitor 74 receptor tyrosine kinase inhibitor 74 Belimumab 74 Seliciclib 73 non peptidic protease 73 Silodosin 73 Lubiprostone 73 Hsp# Inhibitor 73 sodium glucose cotransporter 73 Pazopanib 73 Blinatumomab 73 ADP receptor antagonist 72 Maribavir 72 sorafenib tablets 72 Vidofludimus 72 Bosutinib 72 Voreloxin 72 Elvitegravir 72 ZOLINZA 72 GW# [003] 72 Carfilzomib 72 liposomal formulation 72 Ceflatonin R 72 Glufosfamide 72 Pathway Inhibitor 72 dasatinib Sprycel ® 72 MAGE A3 ASCI 72 talabostat 72 Omacetaxine 72 MKC# MKC# PP 72 Dasatinib 71 Romiplostim 71 Tyrima 71 highly selective inhibitor 71 angiogenesis inhibitor 71 Bafetinib 71 sapacitabine CYC# 71 IMiDs ® 71 HQK 71 PDE4 inhibitor 71 oral prodrug 71 proteasome inhibitor 71 CYT# potent vascular disrupting 71 Aurora Kinase 71 octreotide acetate 71 dasatinib Sprycel 71 HDAC Inhibitor 71 Rigel R# 71 reversible inhibitors 71 Cethromycin 71 Granulocyte Colony Stimulating Factor 71 Anidulafungin 71 novel immunomodulatory 71 Teriflunomide 71 vinca alkaloid 71 Epothilones 71 Temsirolimus 71 Methylnaltrexone 71 Degarelix 71 erlotinib Tarceva ® 71 Panzem R 71 Aliskiren 71 Ustekinumab 71 Tezampanel 71 Pertuzumab 71 signal transduction inhibitor 71 AAG geldanamycin analog 71 docetaxel Taxotere ® 71 anti secretory 70 Archexin 70 chimeric monoclonal antibody 70 5 HT6 receptor 70 Tesetaxel 70 non nucleoside inhibitor 70 IMiDs R 70 Vandetanib 70 microtubule inhibitor 70 LymphoStat B belimumab 70 Cetrorelix pamoate 70 sunitinib Sutent ® 70 IMiDs ® compound 70 regorafenib 70 adenosine A2A 70 Liprotamase 70 kidney urologic 70 class mGluR5 inhibitor 70 GSK '# 70 targeted radiotherapeutic 70 nilotinib Tasigna ® 70 Dapagliflozin 70 Deforolimus 70 ENMD # 70 opioid receptor antagonist 70 nucleotide analogue 70 Pegloticase 70 ARRY # 70 Elesclomol 70 Denufosol 70 SUTENT ® 70 thalidomide Thalomid 70 LY# [003] 70 oral dihydropyrimidine dehydrogenase DPD 70 5 HT3 antagonist 70 Anti Tumor 70 Elotuzumab 70 sorafenib Nexavar 70 cathepsin K inhibitor 70 albiglutide 70 myelofibrosis polycythemia vera 70 PEGylated Fab fragment 70 5 HT2A inverse 69 Golimumab 69 oral antiviral 69 CCX# 69 Enzastaurin 69 TLR9 agonist 69 topical antifungal 69 Traficet EN 69 selective antagonist 69 PI3K/Akt pathway inhibitor 69 sunitinib malate 69 evaluating picoplatin 69 Bucindolol 69 Xanafide 69 Talactoferrin 69 mTOR kinase 69 Romidepsin 69 Bortezomib 69 Aeolus Pharmaceuticals Announces 69 imatinib Gleevec ® 69 Boceprevir 69 HCV RNA polymerase 69 AKT inhibitor 69 Irinotecan 69 immunomodulator 69 selective kinase inhibitor 69 IAP inhibitor 69 novel topoisomerase 69 pertuzumab 69 oral Factor Xa 69 Simulect 69 investigational humanized monoclonal antibody 69 mTOR mammalian target 69 Cloretazine 69 BCG refractory carcinoma 69 small molecule Hedgehog 69 potent topoisomerase II 69 CCR9 antagonist 69 orally administered inhibitor 69 PEG SN# 69 Elagolix 69 small molecule thrombopoietin 69 CYP#A# substrate 69 estrogen receptor antagonist 69 5 HT4 69 EOquin TM phase 69 LHRH antagonists 69 KRN# 69 Initiates Enrollment 69 reslizumab 69 SinuNase ™ 69 HCD# [002] 69 PrevOnco 69 Alfacell proprietary ribonuclease 69 Mg Usa 69 MKC# MT 69 Ocrelizumab 69 Trabectedin 69 LPA1 receptor 69 memantine HCl 69 YONDELIS R 69 candidate deforolimus 69 HCV NS5B polymerase 69 Pradefovir 69 Bezielle 69 Sudhir Agrawal D.Phil 69 Crofelemer budesonide foam 69 unique alkylating agent 69 Ofatumumab 69 agonistic human 69 proteasome inhibitors 69 Epratuzumab 69 delta opioid receptor 69 Dalbavancin 69 selective orally bioavailable 69 peripherally restricted 69 docetaxel Taxotere R 69 HGS ETR1 mapatumumab 69 brand ciclesonide HFA 69 selective modulator 69 NS5b 69 Epidermal Growth Factor Receptor 69 RhuDex ® 69 Kinase Inhibitor 69 RhuDex 69 somatostatin analog 69 Oral NKTR 69 Personalized Immunotherapy 69 Interferon alpha 69 HuLuc# 69 Eculizumab 69 M# rationally 69 Gefitinib 69 polymerase inhibitor 68 Daclizumab 68 IAP inhibitors 68 ganetespib 68 R#/MEM # 68 alkylating agent 68 Bevacizumab 68 oral dual endothelin 68 PDE# 68 AEG# 68 nilotinib Tasigna 68 Cetrorelix 68 Bendamustine 68 Laquinimod 68 Horizant ™ 68 VEGFR2 inhibitor 68 Zorbtive TM 68 PRT# 68 Nitazoxanide 68 pan histone deacetylase 68 selective serotonin 2C receptor 68 somatostatin analogue 68 HCV protease 68 relapsed MM 68 beta 1a 68 D aspartate NMDA receptor 68 Fludara ® 68 Anthracyclines 68 Tasimelteon 68 Ridaforolimus 68 Alemtuzumab 68 Xeloda ® 68 hypereosinophilic syndrome 68 factor Xa 68 Febuxostat 68 Muraglitazar 68 Interferon alfa 68 Lenocta 68 protein tyrosine phosphatase 1B 68 TRO# 68 Arimoclomol 68 samalizumab 68 histone deacetylase HDAC inhibitor 68 Factor VIIa 68 Omalizumab 68 GVAX ® 68 peripherally acting 68 Guanilib 68 mertansine 68 trabectedin 68 small molecule tyrosine 68 novel histone deacetylase 68 tyrosine kinase inhibitor 68 Pimavanserin 68 acyclovir Lauriad R 68 alefacept 68 Successfully Completes Phase 68 HGS# 68 camptothecin CPT 68 vascular disrupting agent 68 Antiangiogenic 68 Meets Primary Endpoint 68 Mg Uk 68 DOXIL 68 Tanespimycin 68 Vidaza azacitidine 68 INCB# [001] 68 Rotigotine 68 midstage clinical 68 Kuvan sapropterin dihydrochloride 68 relapsed leukemia 68 cetuximab Erbitux R 68 paclitaxel Taxol 68 BAY #-# 68 novel oral anticoagulant 68 PSN# [002] 68 bortezomib Velcade 68 MEK Inhibitor 68 MEK inhibitors 68 novel peptide 68 vidofludimus 68 Panzem R NCD 68 synthetic retinoid 68 pralatrexate injection folate analogue 68 Symadex 68 TAFA# 68 Pemetrexed 68 formerly LymphoStat B 68 Noxafil 68 Vicriviroc 68 5 Fluorouracil 68 PSMA ADC 68 small molecule glucokinase 68 Saxagliptin 68 nucleoside analogue 68 Kahalalide F 68 targeted antifolate 68 Pralatrexate 68 IMiDs 68 peptidic compound 68 Bevirimat 68 Valopicitabine 68 telomerase therapeutic 68 cytidine nucleoside analog 68 MEK inhibitor 68 IgG1 monoclonal antibody 68 Aganocide 68 fosbretabulin 68 5 HT2A serotonin 68 BMS # 68 nucleoside reverse transcriptase inhibitor 68 R roscovitine 68 gastrin analogue TT 68 BCR ABL inhibitor 68 Nexavar ® 68 compound perifosine 68 Desvenlafaxine 68 Rilonacept 68 oral immunomodulatory 68 Teplizumab 68 selective inhibition 68 CEQ# 68 daptomycin 68 Sustiva efavirenz 68 plus prednisone prednisolone 67 Immunotherapeutic 67 xanthine oxidase inhibitor 67 cMET 67 Naive Patients 67 Janus kinase 67 accumulate preferentially 67 Aplidin 67 Fulvestrant 67 PNP inhibitor 67 Sym# 67 TNF Tumor Necrosis Factor 67 Valproic acid 67 metaglidasen 67 developing Bicifadine serotonin 67 HuMax EGFr 67 Investigational Treatment 67 Phase 2a Clinical Trial 67 Squalamine 67 Ambrisentan 67 Inhalation Solution 67 HuMax TAC 67 ALS #-# 67 VAPRISOL 67 Fluticasone 67 Vilazodone 67 mitotic kinesin 67 INSPIRE Trial Phase III 67 DU #b 67 Tarceva TM 67 PSN# [001] 67 Warfarin Coumadin 67 Hedgehog Pathway Inhibitor 67 Humanized Anti 67 receptor inhibiting monoclonal 67 cortisol synthesis 67 immune modulatory 67 reversible inhibitor 67 Clevudine 67 Trodusquemine MSI 67 teriflunomide 67 Zolinza 67 SPL# Gel vaginal microbicide 67 SinuNase TM 67 Angiotensin Converting Enzyme 67 Medidur ™ FA 67 radiation sensitizer 67 long acting muscarinic 67 lenalidomide Revlimid R 67 orally bioavailable 67 EGFr 67 topical gel formulation 67 Initiates Clinical 67 Tesamorelin 67 Bayer HealthCare Onyx Pharmaceuticals 67 folate analogue metabolic 67 HGS ETR2 67 IMA# 67 valopicitabine NM# 67 evaluating tivozanib 67 2 methoxyestradiol 67 Microplasmin 67 advanced metastatic renal 67 delta gamma agonist 67 Rasagiline 67 Sphingomab 67 Gleevec imatinib mesylate 67 BRAF inhibitor 67 mTOR inhibitor 67 Virulizin ® 67 oral renin inhibitor 67 Perifosine 67 PEGylated anti 67 dihydrofolate reductase 67 5 HT2A receptor 67 forodesine 67 Pafuramidine 67 triggers apoptosis programmed 67 inflammatory PDE 67 echinocandin 67 Saforis 67 Gemzar ® 67 vascular disrupting agents 67 ixabepilone 67 Olaparib 67 leukotriene receptor antagonist 67 multitargeted 67 intravesical infusion therapy 67 Erlotinib 67 Thiovir 67 CDK cyclin dependent 67 BAL# [002] 67 erlotinib Tarceva 67 direct thrombin inhibitors 67 Beta catenin pathway 67 intranasal formulation 67 OMP #R# 67 Gleevec resistant 67 trastuzumab DM1 T DM1 67 CCR5 mAb 67 Clofarabine 67 Belerofon 67 oral JAK1 67 Gamunex C 67 NPC 1C 67 EndoTAGTM 1 67 Doripenem 67 Velcade bortezomib 67 Trastuzumab DM1 67 systemic antifungal 67 DAVANAT 67 erlotinib Tarceva R 67 lipoglycopeptide 67 Nilotinib 67 fluoroquinolone antibiotic 67 Eltrombopag 67 pan HDAC inhibitor 67 Tofacitinib 67 pemetrexed Alimta 67 Aplidin R 67 Darinaparsin 67 vinorelbine tartrate 67 R sorafenib tablets 67 Melphalan 67 vorinostat 67 alpha folate receptor 67 Varespladib 67 anti androgen 67 endothelin receptor antagonists 67 NXL# 67 Novel Oral 67 Orally administered 67 non porcine pancreatic 67 tasocitinib 67 novel tubulin binding 67 alfa 2a 67 Recombinant Human 67 Akt inhibitor 67 Entry Inhibitor 67 Tocilizumab 67 Nanobody 67 CYC# 67 peptibody 67 Bazedoxifene 67 Panzem 67 efalizumab 67 delivers fluocinolone acetonide FA 67 Aurora kinase 67 Systemic lupus erythematosus SLE 67 anticancer therapeutics 67 Etanercept 67 R memantine HCl 67 MT#/MEDI-# 67 JAK1 67 CYP#A# CYP#D# 67 anticancer compound 67 humanized therapeutic 67 Vimpat R 67 Annamycin 67 atacicept 67 trastuzumab Herceptin R 67 Montelukast 67 Bicalutamide 67 rilonacept 67 TYZEKA 67 histone deacetylase inhibitor 67 Panzem NCD 67 metastatic colorectal 66 Initiates Phase III 66 XYOTAX TM 66 Dabigatran etexilate 66 tubulin inhibitor 66 insulin sensitizing 66 alvespimycin 66 IRX 2 66 Ganciclovir 66 DDP# 66 DEB# 66 Phase #b/#a clinical 66 Phase 2b Clinical Trial 66 HCV protease inhibitors 66 investigational protease inhibitor 66 TREANDA 66 Antithrombin 66 BUPHENYL R 66 oral antifungal 66 PHX# 66 nucleoside analogues 66 GRNOPC1 contains 66 potent triglyceride lowering 66 personalized cellular immunotherapy 66 Cancidas 66 Plicera 66 Paraplatin ® 66 targeting CD# 66 Amrubicin 66 PDX pralatrexate 66 antidiabetic 66 Ozarelix 66 cyclin dependent kinase CDK 66 5 HT4 receptor 66 mda 7 66 2A receptor agonist 66 transdermal spray 66 anti amnesic 66 brivanib 66 virus HCV protease inhibitor 66 humanized monoclonal antibody 66 recombinant PSMA vaccine 66 Randomized Double blind 66 Antitumor Activity 66 Ixabepilone 66 paclitaxel Taxol ® 66 Dose Escalation 66 HSP# inhibitor 66 Oral Fingolimod 66 Amigal 66 plasma kallikrein inhibitor 66 Myelodysplastic Syndrome MDS 66 CD4 monoclonal antibody 66 diarrhea predominant irritable 66 OXi# 66 enhance ApoA 66 Receptor Antagonists 66 PKC# 66 Imatinib mesylate 66 immune modulating 66 Cytarabine 66 ZK EPO 66 Ceftaroline 66 Phase III Pivotal 66 Actemra tocilizumab 66 oncolytic virus therapies 66 injectable investigational 66 cutaneous T 66 novel VDA molecule 66 Phase 2b Trial 66 Tarvacin 66 MGd 66 Otelixizumab 66 Ramelteon 66 immunomodulatory 66 immune modulators 66 Tyrosine Kinase Inhibitor 66 Exemestane 66 TG# [003] 66 HMG CoA reductase inhibitors 66 IMC A# 66 receptor inhibitor 66 Randomized Phase II 66 Pirfenidone 66 CCR5 antagonist 66 Cannabinor 66 Cerimon 66 Bavituximab 66 JAK inhibitors 66 Hormone Refractory Prostate Cancer 66 gastro intestinal inflammation 66 BZL# 66 HepeX B TM 66 ALGRX 66 oral proteasome inhibitor 66 HuMax HepC 66 Reverset 66 tumor vascular disrupting 66 Lenocta TM sodium stibogluconate 66 Safinamide 66 Enzyme Replacement Therapy 66 Phase 2a Trial 66 bortezomib Velcade R 66 acting muscarinic antagonist 66 cyclophosphamide methotrexate 66 Onconase 66 BLP# Liposome Vaccine 66 rHuPH# recombinant human 66 Decitabine 66 nucleotide analog 66 NEUGENE 66 Tumor Necrosis Factor 66 antibody MAb 66 PD LID 66 OMNARIS HFA 66 mitogen activated ERK kinase 66 norepinephrine reuptake inhibitor 66 Tasigna nilotinib 66 Levetiracetam 66 orally dosed 66 phase III isavuconazole 66 HCV protease inhibitor 66 FVIIa 66 IL# PE#QQR 66 protein kinase inhibitor 66 DORIBAX 66 Tigecycline 66 Initiates Phase II 66 TRAIL induced apoptosis 66 Therapeutic Vaccine 66 superficial bladder cancer 66 LAB CGRP 66 Moxifloxacin 66 gefitinib Iressa 66 Factor Receptor 66 sorafenib Nexavar ® 66 Everolimus 66 Transdermal Delivery 66 recurrent glioblastoma multiforme 66 Ophena TM 66 Abatacept 66 active AKT inhibitor 66 neuraminidase inhibitor 66 Lisofylline 66 VA# [002] 66 alpha 2A 66 gastrointestinal stromal tumors GIST 66 non thiazolidinedione TZD 66 ALVESCO ® 66 Investigational Compound 66 Inhaled nitric oxide 66 PI3K/mTOR 66 Telbivudine 66 BAL# [001] 66 Clolar ® 66 Randomized Phase 66 SPRYCEL ® 66 depsipeptide 66 Posaconazole 66 ProMune 66 enzastaurin 66 Aclidinium bromide 66 BHT DNA 66 NS5B polymerase 66 REMINYL ® 66 PEGylated interferon 66 radezolid 66 CCR5 co 66 Completes Patient Enrollment 66 MNTX 66 RhuDex R 66 humanized interleukin 6 66 panitumumab Vectibix 66 integrase inhibitor 66 Litx 66 lapatinib Tykerb 66 Vinorelbine 66 protein mTOR 66 Novel Antibiotic 66 CYP#A# isoenzyme 66 5 HT3 receptor 66 leading oral taxane 66 LY# [002] 66 Quinamed 66 oral nucleoside analogue 66 radiolabeled TM# 66 MKC# 66 Cabazitaxel 66 Abiraterone acetate 66 rhMBL 66 anticancer therapy 66 RGB # 66 developing Zerenex TM 66 Temodar ® 66 IgG1 antibody 66 receptor partial agonist 66 Chemophase 66 XL# XL# 66 pyrimidine nucleoside analog 66 TYGACIL 66 antiviral therapeutics 66 Phase IIb Trial 66 icatibant 66 ELND-#/AZD-# 66 acetonide FA 66 Protease Inhibitor 66 dopamine partial agonist 66 methylnaltrexone 66 Tolvaptan 66 solid tumors ZYBRESTAT 66 biologic DMARD 66 BYETTA ® 66 Onco TCS 66 Granisetron 66 cleavable linker 66 polymerase inhibitors 66 Targretin capsules 66 Lixivaptan 66 REG1 66 CCR5 receptor antagonist 66 directed radiotherapeutic antibody 66 SPRIX ® 66 VIVITROL ® 66 investigational pharmacologically unique 66 Aviptadil 66 Zarnestra 66 Budesonide foam crofelemer 66 dextromethorphan quinidine 66 TNF alpha selectively neutralizing 66 gemcitabine cisplatin 66 hyaluronidase enzyme 66 Exelixis XL# 66 glucagon receptor 66 Peginterferon alfa 2b 66 Anti angiogenic 66 thetreatment 66 Maraviroc 66 investigational HCV polymerase 66 methylnaltrexone bromide 66 Mipomersen 66 Hycamtin 65 Anthracycline 65 itraconazole Sporanox 65 Onrigin 65 6R BH4 65 HDL Mimetic Peptide 65 Bremelanotide 65 investigational integrase inhibitor 65 visilizumab 65 Combunox 65 5 HT6 65 NU# direct 65 prescribed proton pump 65 benign prostatic hypertrophy BPH 65 castrate resistant prostate cancer 65 Vascugel 65 pomalidomide 65 GMX# 65 metformin sulfonylurea 65 Eraxis 65 Aptamer 65 HSP# inhibitors 65 Levofloxacin 65 Albuferon TM 65 octreotide implant 65 antibody trastuzumab 65 oral isotype selective HDAC 65 secretory phospholipase A2 65 ThermoDox R 65 non nucleoside HCV 65 antifibrotic 65 GRN# 65 Arno Therapeutics 65 JAK inhibitor 65 oral chemotherapeutic agent 65 CRMD# 65 Analgesic 65 Genz # 65 Ziprasidone 65 antithrombotic 65 imatinib Gleevec 65 huN# DM1 65 metformin sulfonylureas 65 tigecycline 65 thiazolides 65 DexaSite 65 antitumoral 65 oral transmucosal 65 Cloretazine ® 65 mapatumumab 65 tumor xenograft models 65 Raltegravir 65 vinca alkaloids 65 fluoropyrimidine 65 HER1 65 Icatibant 65 Tumor necrosis factor 65 polysaccharide polymer 65 Naproxcinod 65 TriRima 65 topically applied SEPA 65 JAK2 Inhibitor 65 Taxol ® 65 CCX# B 65 HCV SPRINT 65 BiTE 65 evaluating mipomersen 65 RAS MAPK pathway 65 Delafloxacin 65 pegylated 65 WX UK1 65 Perifosine KRX 65 Systemic Delivery 65 bevacizumab Avastin ® 65 Tipranavir 65 humanized anti 65 Lamictal ODT 65 Zonisamide 65 Alocrest 65 Pruvel TM 65 pathophysiological effects 65 EZN 65 vapreotide acetate 65 recombinant subunit vaccine 65 Prolongs Survival 65 biologic therapy 65 Second Pivotal Phase 65 XL# anticancer compounds 65 Chemotherapeutic 65 Peptide YY 65 ISENTRESS 65 product candidate Lpathomab 65 Initiate Phase III 65 potent antiproliferative 65 ® bortezomib 65 Curaxin CBLC# 65 Campath ® 65 nucleoside analogs 65 Apixaban 65 Certolizumab pegol 65 topical ophthalmic 65 FUSILEV enhances 65 Locked Nucleic Acid 65 TNFerade ™ 65 Solzira ™ 65 anti angiogenic agent 65 TRAIL R2 65 Incretin 65 alpha 2a 65 busulfan 65 Vaprisol 65 mTOR inhibitors 65 treat chronic sinusitis 65 raloxifene Evista 65 Pivotal Phase 65 ONCASPAR 65 Empatic ™ 65 Files IND 65 taxane 65 investigational oral inhibitor 65 Arikace 65 factor Xa inhibitor 65 rhIGFBP 3 65 LHRH antagonist 65 MERREM 65 LibiGel ® 65 TYKERB 65 Phase IIb Clinical Trial 65 SYN# 65 immunomodulating 65 TRPV1 agonist 65 Arranon 65 Liposomal 65 Demonstrates Potent 65 partial agonist 65 luteinizing hormone releasing 65 Genasense ® 65 GSK# [001] 65 eniluracil 65 R lenalidomide 65 EXPAREL TM 65 SAR# [002] 65 inhibits Akt activation 65 E1 INT TM 65 EGFR inhibitors 65 Tapentadol 65 Perforomist ™ Inhalation Solution 65 Bruton tyrosine kinase 65 DermaVir Patch 65 ganciclovir 65 oral picoplatin 65 ACZ# 65 hypoxia inducible factor 65 DGAT 65 Advanced Renal Cell 65 Trandolapril 65 PRTX 65 Rebif ® 65 investigational immunotherapy 65 PORxin TM 65 potent anti angiogenic 65 Tesmilifene 65 paroxetine Paxil 65 LymphoStat B TM 65 BENLYSTA TM 65 Darapladib 65 including eniluracil ADH 65 Celebrex celecoxib 65 selective inverse agonist 65 Fingolimod 65 oral ghrelin agonist 65 RAPTIVA 65 interferon gamma 1b 65 mecamylamine 65 dopamine receptor agonist 65 Cyclophosphamide 65 Anti Tumor Activity 65 BRAF kinase 65 selective inhibitor 65 sargramostim 65 Xelox 65 Oral Spray 65 tocilizumab 65 Lenalidomide 65 seliciclib CYC# 65 RELOVAIR ™ 65 selective estrogen receptor modulator 65 paclitaxel Taxol R 65 AVASTIN 65 ospemifene 65 Crizotinib 65 gabapentin Neurontin 65 Aztreonam lysine 65 Pivotal Phase III 65 CIMZIA TM 65 immunotherapeutic agent 65 delafloxacin 65 LAS# [002] 65 Metastatic Melanoma 65 recurrent metastatic ovarian cancer 65 adalimumab Humira 65 EVIZON TM 65 ALN HTT 65 Cytotoxic 65 Adenoviral 65 histone deacetylase HDAC inhibitors 65 Receptor Agonist 65 SNT MC# 65 Angiolix 65 INTEGRILIN R 65 LT NS# 65 Talotrexin 65 Atripla combines 65 Adalimumab 65 Cardiotoxicity 65 MSCRAMM ® 65 Nutra Pharma wholly owned 65 relapsed multiple myeloma 65 Ticagrelor 65 T#I [002] 65 vemurafenib 65 immune stimulatory 65 drug pipeline TAFA# 65 Immunomodulatory 65 oral Janus kinase 65 Taxanes 65 investigational oral 65 neuropathic pain metabolic diseases 65 MGCD# [001] 65 CINQUIL 65 Diabetic Neuropathy 65 HER2 positive metastatic breast 65 cyclin dependent kinase inhibitor 65 trastuzumab Herceptin ® 65 anti CD3 65 Initiate Phase 65 TRANSDUR ® 65 Trastuzumab 65 dexpramipexole 65 Sitagliptin 65 Gemcitabine 65 beta lactamase inhibitor 65 gemcitabine Gemzar ® 65 therapeutic monoclonal antibody 65 Aztreonam 65 elotuzumab 65 BLyS specific 65 TOCOSOL Camptothecin 65 Imprime PGG 65 meropenem 65 constipation OIC 65 ACTEMRA TM 65 MTP inhibitor 65 Bruton tyrosine kinase Btk 65 Formoterol 65 indibulin 65 Linaclotide 65 tizanidine hydrochloride short 65 CRTH2 65 long acting bronchodilator 65 chemokine receptor